Ablacon: Ablacon, Inc. : Announces $30 Million Series B Financing and Expansion of Scientific Advisory Board

(marketscreener.com) MENLO PARK, Calif., Jan. 7, 2021 /PRNewswire/ -- Ablacon, Inc., an Ajax Health-backed company, announced the close of a $30 million Series B financing, with Zeus Health joining as new lead investor. Ablacon also announced the addition of Dr. David Haines, Professor of Cardiovascular Medicine at Oakland University William Beaumont...https://www.marketscreener.com/news/latest/Ablacon-Inc-Announces-30-Million-Series-B-Financing-and-Expansion-of-Scientific-Advisory-Board--32139008/?utm_medium=RSS&utm_content=20210107